Search Results
Found 1 results
510(k) Data Aggregation
(262 days)
NEXA Negative Pressure Wound Therapy System
The NEXA NPWT system is intended for patients who may benefit from the application of negative pressure to the wound to promote wound healing through the removal of excess exudate, infectious material and tissue debris.
It is intended for use in long-term care and acute settings only when prescribed by a Health Care Professional.
Appropriate wound types include:
- Chronic wounds
- · Pressure ulcers
- · Diabetic foot ulcers
- · Venous leg ulcers
The NEXA NPWT System is an integrated negative pressure wound management system for use in acute and extended care settings. The system applies a negative pressure to a sealed wound dressing and promotes wound healing through the removal of exudates into a disposable fluid container.
The system consists of the following key components:
- NEXA Device: A portable device that contains a pump and a rechargeable Battery and is supplied with a Power Supply and a Carry Case.
- NEXA Fluid Container Pack: A single use polymeric flexible fluid container that stores the exudate removed from the wound.
- NEXA Dressing: Sterile single use wound dressing components that are in contact with the wound tissue and a means of sealing to the periwound area. Interconnect tubing includes an integrated negative pressure relief valve that limits the maximum pressure able to be applied to the wound and are pre-set and not adjustable by the user.
The provided document is a 510(k) premarket notification for the Nexa Negative Pressure Wound Therapy System. It describes the device, its intended use, and compares it to a predicate device. However, it does not contain information about a study proving the device meets specific acceptance criteria in the way a clinical trial or AI performance study would.
The "Performance data" section (Page 7) describes non-clinical bench testing undertaken to demonstrate substantial equivalence to the predicate device, not a study against predefined clinical acceptance criteria. There is a specific note on Page 8: "Summary of clinical tests conducted for determination of substantial equivalence or of clinical information [21 CFR 807.92(b)(2)] - Not applicable." This confirms that no clinical studies were performed or are being reported in this submission for determining substantial equivalence or clinical performance.
Therefore, for your requests regarding acceptance criteria and a study proving the device meets them, the answer based on this document is that the document does not provide this information in the context of clinical performance or AI-related metrics.
However, I can extract information related to the bench testing that was conducted to support the substantial equivalence claim.
Based on the provided document, here's what can be extracted regarding the non-clinical bench testing used to demonstrate substantial equivalence:
1. A table of acceptance criteria and the reported device performance
The document describes bench testing objectives rather than specific quantitative acceptance criteria with reported numerical device performance in the format requested. The objectives served as the "criteria" for demonstrating substantial equivalence to the predicate device.
Acceptance Criteria (Bench Test Objectives) | Reported Device Performance (as stated in the document) |
---|---|
Device effectively removes wound fluid across a range of viscosities and positions. | "candidate device effectively removes wound fluid in a clinically relevant setting across a range of viscosities and positions" (Qualitative statement) |
Device generates the stated negative pressure at the wound site. | "candidate device generates the stated negative pressure at the wound site" (Qualitative statement) |
Device alert and warning system works as intended. | "device alert and warning system works as intended" (Qualitative statement) |
Duration of the battery life is as stated in the Instructions. | "duration of the battery life is as stated in the Instructions" (Qualitative statement) |
Device performs as intended over its stated life cycle. | "device performs as intended over its stated life cycle" (Qualitative statement) |
Components with a stated shelf life perform as intended over the stated life. | "components with a stated shelf life i.e. dressing components perform as intended over the stated life" (Qualitative statement) |
Comparative performance testing against the predicate. | "Comparative performance testing against the predicate" was undertaken (Qualitative statement, implying it performed comparably to the predicate for the tested aspects). |
Biocompatibility requirements met. | "Bio-compatibility testing was undertaken with the final materials subjected to production processes." (Qualitative statement, referring to expert review and testing) |
Electrical Safety, Usability, EMC & Packaging standards met. | Compliance with listed IEC and ISO standards (e.g., IEC 60601-1, IEC 62366, EN 60601-1-2, ISTA 2, BS EN ISO 3744) (Qualitative statement) |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document describes "bench performance testing conducted using simulated wound exudates using wound models over a range of clinically relevant conditions." It does not specify the sample size (e.g., number of tests, number of devices tested) for these bench tests. Data provenance is not detailed beyond the general statement of "bench testing."
Regarding biocompatibility, an "independent test facility" was used, certified to international standards. The country of origin for this testing or data is not specified.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
For the non-clinical bench testing, the concept of "ground truth" and "experts" as typically understood in clinical or AI studies (e.g., radiologists interpreting images) is not applicable. The bench tests are objective measurements against defined physical/engineering parameters.
For biocompatibility, an "expert review was completed by an independent test facility" to evaluate test requirements. The number and qualifications of these experts are not specified beyond being from a certified independent test facility.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable, as this was non-clinical bench testing, not an observational or clinical study requiring adjudication of findings.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The document explicitly states: "Summary of clinical tests conducted... Not applicable." (Page 8)
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This device is a physical medical device (Negative Pressure Wound Therapy system), not an AI algorithm. Therefore, the concept of "standalone (algorithm only)" performance is not applicable.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For the bench testing, the "ground truth" would be the expected physical performance parameters (e.g., target negative pressure, defined flow rate for fluid removal, specified battery life) according to the device's design specifications and comparison to the predicate device's known performance characteristics. These are objective engineering measurements rather than clinical ground truth like pathology or outcomes data.
8. The sample size for the training set
Not applicable, as this is a physical medical device, not an AI system that requires a training set.
9. How the ground truth for the training set was established
Not applicable, as this is a physical medical device, not an AI system.
Ask a specific question about this device
Page 1 of 1